These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6306294)

  • 21. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefmenoxime: clinical evaluation.
    Baker RL; Perkins RL
    Am J Med; 1984 Dec; 77(6A):53-9. PubMed ID: 6097126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological and clinical studies of cefodizime in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infections associated with hematological disorders].
    Uchida T; Matsuda S; Kimura H; Satoh T; Ishibashi T; Kokubun K; Umezu H; Horikawa A; Saitoh T; Sakauchi Y
    Jpn J Antibiot; 1984 Dec; 37(12):2506-18. PubMed ID: 6098743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infection associated with hematological disorders].
    Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Kanazawa T; Kawazu S; Tsuge M; Tanabe K; Nara H; Aizawa M
    Jpn J Antibiot; 1986 May; 39(5):1250-8. PubMed ID: 3463775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of cefmenoxime and cefsulodin in the treatment of complicated urinary tract infections caused by Pseudomonas aeruginosa.
    Doi T; Nishiura T; Deguchi K; Kondo M
    Chemotherapy; 1986; 32(3):299-304. PubMed ID: 3458567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on ceftriaxone in the pediatric field].
    Aoyama R; Ito E; Ohnishi A; Izumi Y; Nagata K; Yokoyama M; Kuronuma T; Fujita M
    Jpn J Antibiot; 1984 Nov; 37(11):2012-4. PubMed ID: 6098696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
    Zhao C; Li J; Hao F
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):465-8. PubMed ID: 10436948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum levels and sputum levels of cefmenoxime in respiratory tract infections].
    Matsumoto Y; Ninomaru S; Koshobu T; Ishikawa J; Nakatani S; Sasaki T
    Jpn J Antibiot; 1985 Jun; 38(6):1638-42. PubMed ID: 3862881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of ceftriaxone in pediatric infections].
    Ohnuma M; Watanabe A
    Jpn J Antibiot; 1984 Nov; 37(11):2015-20. PubMed ID: 6098697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic efficacies of suppository of ceftizoxime against experimental infections in mice].
    Obana Y; Nishino T; Tanino T
    Jpn J Antibiot; 1985 Dec; 38(12):3458-63. PubMed ID: 3869265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
    Guibert J; Acar JF; Destree D; Bryskier A
    Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical results of cefuroxime (CXM) therapy in pediatric infections (author's transl)].
    Nakamura Y; Yanagisawa K; Ichihashi H
    Jpn J Antibiot; 1979 Nov; 32(11):1132-6. PubMed ID: 390177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
    Hall MJ; Westmacott D; Wong-Kai-In P
    J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical studies on cefixime in pediatrics].
    Mikawa H; Mayumi M; Akiyama Y; Ito S; Watanabe Y; Kanaoka H; Takeshita S; Takahashi Y; Akiyama F; Yoshimura T
    Jpn J Antibiot; 1989 Dec; 42(12):2527-39. PubMed ID: 2693753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.
    Tan JS; File TM
    Am J Med; 1984 Dec; 77(6A):51-2. PubMed ID: 6097125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.